0000000000061967

AUTHOR

Pierpaolo Alongi

0000-0002-8397-1640

showing 20 related works from this author

Theragnostic Use of Radiolabelled Dota-Peptides in Meningioma: From Clinical Demand to Future Applications.

2019

Meningiomas account for approximately 30% of all new diagnoses of intracranial masses. The 2016 World Health Organization’s (WHO) classification currently represents the clinical standard for meningioma’s grading and prognostic stratification. However, watchful waiting is frequently the chosen treatment option, although this means the absence of a certain histological diagnosis. Consequently, MRI (or less frequently CT) brain imaging currently represents the unique available tool to define diagnosis, grading, and treatment planning in many cases. Nonetheless, these neuroimaging modalities show some limitations, particularly in the evaluation of skull base lesions. The emerging evidence supp…

Cancer Researchmedicine.medical_specialtypositron emission tomographymedicine.medical_treatmentReviewlcsh:RC254-282meningioma030218 nuclear medicine & medical imagingMeningioma03 medical and health sciences0302 clinical medicineNeuroimagingFunctional neuroimagingmedicineotorhinolaryngologic diseasesMedical diagnosisRadiation treatment planningGrading (tumors)neoplasmsMeningioma; Neuroimaging; Positron emission tomography; Radionuclide therapy; Somatostatin receptorneuroimagingbusiness.industryradionuclide therapylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseasesomatostatin receptorOncologymeningioma; somatostatin receptor; neuroimaging; positron emission tomography; radionuclide therapy030220 oncology & carcinogenesisRadionuclide therapyRadiologybusinessWatchful waitingCancers
researchProduct

Stereotactic body radiation therapy for liver oligometastases: predictive factors of local response by 18F-FDG-PET/CT

2018

Objective:To investigate metabolic parameters as predictive of local response after stereotactic body radiation therapy (SBRT) for liver-oligometastases.Methods:Inclusion criteria of the present re...

medicine.medical_specialtyStereotactic body radiation therapybusiness.industryLiver NeoplasmsHumans; Liver Neoplasms; Retrospective Studies; Treatment Outcome; Fluorodeoxyglucose F18; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiosurgery; Radiology Nuclear Medicine and ImagingGeneral MedicineRadiosurgery030218 nuclear medicine & medical imaging03 medical and health sciencesTreatment Outcome0302 clinical medicineFluorodeoxyglucose F18Positron Emission Tomography Computed TomographyNuclear Medicine and Imaging030220 oncology & carcinogenesisHumansMedicineRadiology Nuclear Medicine and imagingFdg pet ctRadiologyRadiopharmaceuticalsRadiologybusinessRetrospective StudiesThe British Journal of Radiology
researchProduct

[11C]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile a…

2010

[11C]choline positron emission tomograhy can be useful to detect metastatic disease and to localize isolated lymph node relapse after primary treatment in case of prostate-specific antigen failure. In case of lymph node failure in prostate cancer patients, surgery or radiotherapy can be proposed with a curative intent. Some reports have suggested that radiotherapy could have a role in local control of oligometastatic lymph node disease. This is the first reported case of [11C]choline positron emission tomography-guided helical tomotherapy concomitant with estramustine for the treatment of pelvic-recurrent prostate cancer. At 24 months after the end of helical tomotherapy, prostate-specific…

OncologyMaleCancer Researchmedicine.medical_treatment[11C]choline-PET tomotherapy prostate relapse lymph node030218 nuclear medicine & medical imagingCholineProstate cancer0302 clinical medicineProstateCarbon RadioisotopesTomographyLymph nodeAdjuvantPelvic NeoplasmsrelapseprostateGeneral MedicineAlkylatingmedicine.anatomical_structureTreatment OutcomeLocalOncologyChemotherapy Adjuvant030220 oncology & carcinogenesis[11C]choline-PETEstramustineAged; Antineoplastic Agents Alkylating; Antineoplastic Agents Hormonal; Carbon Radioisotopes; Chemotherapy Adjuvant; Choline; Estramustine; Humans; Male; Neoplasm Recurrence Local; Pelvic Neoplasms; Prostatic Neoplasms; Radiotherapy Adjuvant; Treatment Outcome; Positron-Emission Tomography; Tomography Spiral ComputedEstramustinemedicine.drugmedicine.medical_specialtyAntineoplastic Agents HormonaltomotherapyAntineoplastic AgentsTomotherapy03 medical and health sciencesInternal medicinemedicinelymphChemotherapyHumansAntineoplastic Agents AlkylatingAgedChemotherapyHormonalRadiotherapybusiness.industryProstatic Neoplasmsmedicine.diseaseRadiation therapyNeoplasm RecurrenceConcomitantPositron-Emission TomographySpiral ComputedRadiotherapy AdjuvantNeoplasm Recurrence LocalbusinessTomography Spiral Computed
researchProduct

79. Amyloid-PET analysis based on tissue probability maps

2018

Purpose The regional quantification of amyloid burden is crucial for the clinical diagnosis of Alzheimer’s disease [1]. The best method to evaluate regional amyloid deposition in PET is through the use MR imaging for brain space normalization. However, since MR imaging is not always available in the clinical practice, a MR-less methodology is needed in order to compute semi-quantitative and analyze regional amyloid burden. Methods Forty-four patients with clinical evidence of dementia, underwent 18F-Florbetaben PET (FBB-PET), FDG-PET, neuropsychological assessment and cerebrospinal fluid analysis. We implemented a methodology that uses SPM12 to import and normalize the FBB-PET images in Mon…

Normalization (statistics)medicine.diagnostic_testReceiver operating characteristicbusiness.industryBiophysicsPrecuneusGeneral Physics and AstronomyAmyloid petGeneral Medicinemedicine.diseasemedicine.anatomical_structuremedicineDementiaCutoffRadiology Nuclear Medicine and imagingNeuropsychological assessmentParacentral lobuleNuclear medicinebusinessPhysica Medica
researchProduct

Choline PET/CT Features to Predict Survival Outcome in High Risk Prostate Cancer Restaging: A Preliminary Machine-Learning Radiomics Study

2020

Background Radiomic features are increasingly utilized to evaluate tumor heterogeneity in PET imaging but to date its role has not been investigated for Cho-PET in prostate cancer. The potential application of radiomics features analysis using a machine-learning radiomics algorithm was evaluated to select 18F-Cho PET/CT imaging features to predict disease progression in PCa. Methods We retrospectively analyzed high-risk PCa patients who underwent restaging 18F-Cho PET/CT from November 2013 to May 2018. 18F-Cho PET/CT studies and related structures containing volumetric segmentations were imported in the "CGITA" toolbox to extract imaging features from each lesion. A Machine-learning model h…

Malemedicine.medical_specialtyn artificial intelligence model demonstrated to be feasible and able to select a panel of 18F-Cho PET/CT features with valuable association with PCa patients' outcome.business.industryProstatic NeoplasmsFeature selectionPet imagingCholine pet ctmedicine.diseaseTumor heterogeneitySurvival outcomeCholineMachine LearningProstate cancerRadiomicsFeature (computer vision)Artificial IntelligencePositron Emission Tomography Computed TomographyMedicineHumansRadiology Nuclear Medicine and imagingRadiologybusinessRetrospective Studies
researchProduct

Whole body magnetic resonance in indolent lymphomas under watchful waiting: The time is now.

2017

The indolent non-Hodgkin lymphomas (i-NHLs) are characterised by ‘indolent’ clinical behaviour with slow growth and prolonged natural history. The watchful waiting (WW) strategy is a frequently employed treatment option in these patients. This implies a strict monitoring by imaging examinations, including 18F-fluorodeoxyglucose-positron emission tomography/computed tomography (18F-FDG-PET/CT) and CT. A major concern is radiation exposure due to regularly monitoring by conventional imaging procedures. Several studies have demonstrated the reliability of whole-body magnetic resonance imaging (WB-MRI) for lymphoma staging. WB-MRI could be useful for active surveillance in i-NHLs providing the …

medicine.medical_specialtyLymphomamedicine.medical_treatmentWhole body imaging030218 nuclear medicine & medical imaging03 medical and health sciencesMagnetic resonance imaging0302 clinical medicineimmune system diseaseshemic and lymphatic diseasesmedicinemedia_common.cataloged_instanceHumansRadiology Nuclear Medicine and imagingWhole Body ImagingEuropean unionWatchful WaitingNeuroradiologymedia_commonmedicine.diagnostic_testbusiness.industryLymphoma Non-HodgkinReproducibility of ResultsMagnetic resonance imagingInterventional radiologyGeneral Medicinemedicine.diseaseLymphomaRadiation therapyDiffusion Magnetic Resonance Imaging030220 oncology & carcinogenesisDisease ProgressionIonising radiationRadiologybusinessWatchful waitingEuropean radiology
researchProduct

Potential clinical value of quantitative fluorine-18-fluorodeoxyglucose-PET/computed tomography using a graph-based method analysis in evaluation of …

2019

Objectives To identify the clinical relevance of incidentally detected lesions (IDLs) in the gastrointestinal tract (GIT) with 18F-FDG PET/CT and to assess the potential benefit of using semiquantitative PET measures to discern malignant from benign lesions. Methods Forty-one patients who underwent F-FDG PET/CT scans during the oncologic follow-up, revealing abnormal incidental 18F-FDG accumulations in the GIT were included in this retrospective analysis. Incidental PET/CT findings were correlated with endoscopic and histological findings. Semiquantitative PET values (SUVmax, SUVmean, SULpeak, and TLG) were evaluated by using a new graph-based method. Two sample t-test analysis has been per…

AdultMale-Endoscopy Gastrointestinal030218 nuclear medicine & medical imagingCorrelation03 medical and health sciences0302 clinical medicineFluorodeoxyglucose F18Positron Emission Tomography Computed TomographyBiopsymedicineImage Processing Computer-AssistedHumansRadiology Nuclear Medicine and imagingClinical significanceGastrointestinal NeoplasmsRetrospective StudiesGastrointestinal tractIncidental FindingsFluorine-18-fluorodeoxyglucosemedicine.diagnostic_testbusiness.industryRetrospective cohort studyGeneral Medicinemedicine.diseaseEndoscopyTumor BurdenDysplasia030220 oncology & carcinogenesisFemalebusinessNuclear medicineGlycolysisNuclear medicine communications
researchProduct

Radiomics Analysis of Brain [18F]FDG PET/CT to Predict Alzheimer’s Disease in Patients with Amyloid PET Positivity: A Preliminary Report on the Appli…

2022

Background: Early in-vivo diagnosis of Alzheimer’s disease (AD) is crucial for accurate management of patients, in particular, to select subjects with mild cognitive impairment (MCI) that may evolve into AD, and to define other types of MCI non-AD patients. The application of artificial intelligence to functional brain [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography(CT) aiming to increase diagnostic accuracy in the diagnosis of AD is still undetermined. In this field, we propose a radiomics analysis on advanced imaging segmentation method Statistical Parametric Mapping (SPM)-based completed with a Machine-Learning (ML) application to predict the diagnosi…

radiomics; Alzheimer’s disease; PET/CT; machine learningAlzheimer’s disease; machine learning; PET/CT; radiomicsmachine learningPET/CTradiomicsradiomicClinical Biochemistryradiomics; Alzheimer's disease; PET/CT; machine learningAlzheimer’s diseaseDiagnostics
researchProduct

Clinical and prognostic value of 18F-FDG-PET/CT in restaging of pancreatic cancer

2018

Aim The aim of this retrospective multicentre study was to evaluate the clinical and prognostic effect of fluorine-18-fluorodeoxyglucose (18F-FDG)-PET/computed tomography (CT) in the restaging process of pancreatic cancer (PC). Materials and methods Data from patients treated for primary PC, who underwent18F-FDG-PET/CT for suspicious of disease progression, were collected. Accuracy was assessed employing conventional diagnostic procedures, multidisciplinary team case notes, further18F-FDG-PET/CT scans and/or follow-up. Receiver operating characteristic curve and likelihood ratio (LR+/-) analyses were used for completion of accuracy definition. Progression-free survival (PFS) and overall sur…

AdultMalePrognosioverall survival18F-FDG-PET/CTpancreatic cancer030218 nuclear medicine & medical imaging03 medical and health sciencesdisease progression0302 clinical medicineRetrospective StudieFluorodeoxyglucose F18Positron Emission Tomography Computed TomographyPancreatic cancerrestagingHumansMedicineRadiology Nuclear Medicine and imagingProgression-free survivalRetrospective StudiesAgedNeoplasm StagingReceiver operating characteristicbusiness.industryProportional hazards modelHazard ratioPancreatic NeoplasmArea under the curveRetrospective cohort studyGeneral MedicineMiddle AgedPrognosismedicine.diseaseConfidence intervalPancreatic Neoplasms030220 oncology & carcinogenesisFemalebusinessNuclear medicineprogression-free survivalHumanNuclear Medicine Communications
researchProduct

Radiomics analysis of 18F-Choline PET/CT in the prediction of disease outcome in high-risk prostate cancer: an explorative study on machine learning …

2021

Objective: The aim of this study was (1) to investigate the application of texture analysis of choline PET/CT images in prostate cancer (PCa) patients and (2) to propose a machine-learning radiomics model able to select PET features predictive of disease progression in PCa patients with a same high-risk class at restaging. Material and methods: Ninety-four high-risk PCa patients who underwent restaging Cho-PET/CT were analyzed. Follow-up data were recorded for a minimum of 13 months after the PET/CT scan. PET images were imported in LIFEx toolbox to extract 51 features from each lesion. A statistical system based on correlation matrix and point-biserial-correlation coefficient has been impl…

Malemedicine.medical_specialtyMachine learningcomputer.software_genre030218 nuclear medicine & medical imagingCholineCorrelationMachine Learning03 medical and health sciences0302 clinical medicineArtificial IntelligencePositron Emission Tomography Computed TomographymedicineHumansRadiology Nuclear Medicine and imagingCholine; Machine learning; Positron emission tomography computed tomography; Prostate cancer; Radiomics.Prospective StudiesEntropy (energy dispersal)Prospective cohort studySurvival analysisPET-CTbusiness.industryProstatic NeoplasmsGeneral MedicineLinear discriminant analysismedicine.diseasePrimary tumorFeature (computer vision)030220 oncology & carcinogenesisRadiologyArtificial intelligenceNeoplasm Recurrence LocalbusinesscomputerMachine learning Positron emission tomography computed tomography Prostate cancer Radiomics Artificial Intelligence
researchProduct

10-Year Clinical Experience With 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 Patients.

2020

Purpose The primary aim of this multicenter retrospective analysis is to examine the role of(18)F-choline PET/CT as a diagnostic tool for staging and restaging prostate cancer (PCa) in a large population in the light of 10 years of clinical experience. A secondary aim of the study is to produce data on the predictors of a positive(18)F-choline PET/CT result in the setting of PCa primaries and biochemical recurrences. Materials and Methods This multicenter retrospective cohort study is based on data collected by 9 Italian nuclear medicine departments. Between October 2008 and September 2019, 3343 men underwent(18)F-choline PET/CT scans before receiving definitive treatments for a primary PCa…

Biochemical recurrenceMalemedicine.medical_specialtyProstate biopsyrecurrencePET/CTcholine; PET/CT; prostate cancer; recurrence; staging030218 nuclear medicine & medical imagingCholine03 medical and health sciencesProstate cancer0302 clinical medicineSettore MED/36ProstatePositron Emission Tomography Computed Tomography80 and overMedicineHumansRadiology Nuclear Medicine and imagingTomographyCancer stagingAgedAged 80 and overPET-CTmedicine.diagnostic_testbusiness.industryProstatic NeoplasmsRetrospective cohort studyGeneral MedicinestagingMiddle Agedmedicine.diseaseprostate cancerX-Ray ComputedProstate-specific antigenmedicine.anatomical_structurePET030220 oncology & carcinogenesisRadiologyNeoplasm GradingRadiopharmaceuticalsbusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaTomography X-Ray ComputedCT; choline; prostate cancer; recurrence; staging; Aged; Aged 80 and over; Choline; Humans; Male; Middle Aged; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography X-Ray ComputedCTClinical nuclear medicine
researchProduct

The role of PET radiomic features in prostate cancer: a systematic review

2021

Aim: This systematic review aims to present the available evidence on the use of radiomic features (RFs) extracted from PET imaging in patients with prostate cancer (PCa). Materials and methods: A comprehensive literature search of studies on the utility of PET-derived RFs in patients with PCa was performed in the PubMed/MEDLINE database through February 24th, 2021 using the following search string: [“positron-emission tomography” (MeSh terms) OR “positron emission tomography computed tomography” (MeSh terms) OR “positron-emission tomography” (all fields) OR “positron emission tomography computed tomography” (all fields) OR “PET” (all fields)] AND [“radiomics” (all fields) OR “radiomic” (al…

medicine.medical_specialtyPositron emission tomographymedicine.medical_treatmentRadiogenomics030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancer0302 clinical medicineProstateMachine learningCarcinomamedicineRadiology Nuclear Medicine and imagingLymph nodeProstate cancerRadiomicsmedicine.diagnostic_testbusiness.industryInterventional radiologyDeep learningmedicine.diseaseRadiation therapymedicine.anatomical_structure030220 oncology & carcinogenesisRadiologyTomographybusiness
researchProduct

Inflammatory Pseudotumor of Mediastinum Treated with Tomotherapy and Monitored with FDG-PET/CT: Case Report and Literature Review

2010

Mediastinal inflammatory pseudotumor is a rare disease with reactive pseudoneoplastic features and a proven capacity for local invasion. The radiographic appearance of inflammatory pseudotumor is quite non-specific and the definitive diagnosis is based on the histological evaluation of tissue specimens. Resection of the lesion is the treatment of choice. However, nonsurgical treatments such as radiotherapy and steroids have been employed in the setting of incomplete surgical resection, tumor recurrence, and patients being unfit for surgery. The case described here is being reported because of the rare mediastinal location and atypical treatment approach including salvage irradiation and mon…

AdultCancer Researchmedicine.medical_specialtyPET/CTRadiographymedicine.medical_treatmenttomotherapyAdult; Granuloma Plasma Cell; Humans; Mediastinal Neoplasms; Positron-Emission Tomography; Tomography X-Ray Computed; Fluorodeoxyglucose F18; RadiopharmaceuticalsMediastinal NeoplasmsGranuloma Plasma CellTomotherapy030218 nuclear medicine & medical imagingInflammatory pseudotumorLesion03 medical and health sciences0302 clinical medicineFluorodeoxyglucose F18HumansMedicineTomographyPET-CTGranulomabusiness.industryMediastinumGeneral MedicinemediastinumX-Ray ComputedRadiation therapymedicine.anatomical_structureOncologyPositron-Emission TomographyPlasma CellInflammatory pseudotumorRadiologyRadiopharmaceuticalsmedicine.symptomTomography X-Ray Computedbusiness030217 neurology & neurosurgeryRare diseaseTumori Journal
researchProduct

18F-Florbetaben PET/CT to Assess Alzheimer's Disease: A new Analysis Method for Regional Amyloid Quantification.

2019

Background and purpose While AD can be definitively confirmed by postmortem histopathologic examination, in vivo imaging may improve the clinician's ability to identify AD at the earliest stage. The aim of the study was to test the performance of amyloid PET using new processing imaging algorithm for more precise diagnosis of AD. Methods Amyloid PET results using a new processing imaging algorithm (MRI-Less and AAL Atlas) were correlated with clinical, cognitive status, CSF analysis, and other imaging. The regional SUVR using the white matter of cerebellum as reference region and scores from clinical and cognitive tests were used to create ROC curves. Leave-one-out cross-validation was carr…

Male18F-florbetabenAmyloidSensitivity and SpecificityAmyloid-PET Imaging030218 nuclear medicine & medical imagingWhite matter03 medical and health sciences0302 clinical medicineAlzheimer DiseasePositron Emission Tomography Computed Tomographymental disordersStilbenesmedicineImage Processing Computer-AssistedDementiaHumansRadiology Nuclear Medicine and imaging18F-florbetaben; Alzheimer's disease; Amyloid-PET Imaging; MR-lessAgedRetrospective StudiesPET-CTAniline CompoundsReceiver operating characteristicbusiness.industry18F-florbetaben Alzheimer's disease Amyloid-PET Imaging MR-less Aged Alzheimer Disease Female Humans Image Processing Computer-Assisted Magnetic Resonance Imaging Male Positron Emission Tomography Computed Tomography Retrospective Studies Sensitivity and Specificity Aniline Compounds StilbenesAlzheimer's diseasemedicine.diseaseMagnetic Resonance Imagingmedicine.anatomical_structureMR-lessFemaleNeurology (clinical)Differential diagnosisNuclear medicinebusiness030217 neurology & neurosurgeryPreclinical imagingFrontotemporal dementiaJournal of neuroimaging : official journal of the American Society of Neuroimaging
researchProduct

Diagnostic accuracy of cerebrospinal fluid biomarkers measured by chemiluminescent enzyme immunoassay for Alzheimer disease diagnosis.

2020

In the last decades, an important role of cerebrospinal fluid (CSF) biomarkers for Alzheimer disease (AD) diagnosis has emerged. The evaluation of the triad consisting of 42 aminoacid-long amyloid-beta peptide (Aβ42), total Tau (tTau) and Tau phosphorylated at threonine 181 (pTau) have been recently integrated into the research diagnostic criteria of AD. For a long time, the enzyme-linked immunosorbent assay (ELISA) has represented the most commonly used method for the measurement of CSF biomarkers levels. This study aimed to assess the diagnostic accuracy of CSF biomarkers, namely Aβ42, tTau and pTau and their ratio, measured by fully automated CLEIA assay (Lumipulse). We included 96 patie…

0301 basic medicineMalePathologymedicine.medical_specialtyAmyloidClinical Biochemistrychemiluminescent enzyme immunoassay methodCSF biomarkerDiagnostic accuracyEnzyme-Linked Immunosorbent Assaytau Proteinslaw.invention03 medical and health sciences0302 clinical medicineCerebrospinal fluidliquorlawAlzheimer DiseasemedicineHumansPhosphorylationChemiluminescenceAgedchemistry.chemical_classificationAutomation LaboratoryAmyloid beta-Peptidesmedicine.diagnostic_testbusiness.industryGeneral MedicineCLEIAMiddle Agedmedicine.diseasePeptide Fragments030104 developmental biologyEnzymechemistryROC CurveImmunoassayArea Under CurveCase-Control StudiesCsf biomarkersLuminescent MeasurementsFemaleAlzheimer's diseasebusiness030217 neurology & neurosurgeryBiomarkersScandinavian journal of clinical and laboratory investigation
researchProduct

Imaging features of adrenal masses

2019

Abstract The widespread use of imaging examinations has increased the detection of incidental adrenal lesions, which are mostly benign and non-functioning adenomas. The differentiation of a benign from a malignant adrenal mass can be crucial especially in oncology patients since it would greatly affect treatment and prognosis. In this setting, imaging plays a key role in the detection and characterization of adrenal lesions, with several imaging tools which can be employed by radiologists. A thorough knowledge of the imaging features of adrenal masses is essential to better characterize these lesions, avoiding a misinterpretation of imaging findings, which frequently overlap between benign …

Adenomalcsh:Medical physics. Medical radiology. Nuclear medicinemedicine.medical_specialtyAdenomalcsh:R895-920ReviewImaging modalitiesAdrenal massesMagnetic resonance imagingMedicineRadiology Nuclear Medicine and imagingAdrenal imagingAdrenalComputed tomographyNeuroradiologymedicine.diagnostic_testbusiness.industryMagnetic resonance imagingInterventional radiologymedicine.diseaseSettore MED/18 - Chirurgia GeneraleOncology patientsRadiologySettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessChemical shift imagingInsights into Imaging
researchProduct

Multiparametric MRI and Radiomics in Prostate Cancer: A Review of the Current Literature

2021

Prostate cancer (PCa) represents the fourth most common cancer and the fifth leading cause of cancer death of men worldwide. Multiparametric MRI (mp-MRI) has high sensitivity and specificity in the detection of PCa, and it is currently the most widely used imaging technique for tumor localization and cancer staging. mp-MRI plays a key role in risk stratification of naïve patients, in active surveillance for low-risk patients, and in monitoring recurrence after definitive therapy. Radiomics is an emerging and promising tool which allows a quantitative tumor evaluation from radiological images via conversion of digital images into mineable high-dimensional data. The purpose of radiomics is to…

medicine.medical_specialtyMedicine (General)Clinical BiochemistryReviewProstate cancerR5-920RadiomicsProstatemedicinemagnetic resonance imagingcancerGleason scoreCancer stagingPI-RADSprostatemedicine.diagnostic_testbusiness.industryCancerMultiparametric MRIMagnetic resonance imagingmedicine.diseasePI-RADSmedicine.anatomical_structureradiomicsRadiologybusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaDiagnostics
researchProduct

Clinical and Prognostic Value of 18F-FDG-PET/CT in the Restaging Process of Recurrent Cutaneous Melanoma

2020

Background: Several studies on 18F-FDG-PET/CT have investigated the prognostic role of this imaging modality in different tumors after treatment. Nevertheless, its role in restaging patients with recurrent CM still needs to be defined. Objective: The aim of this retrospective multicenter study was to evaluate the clinical and prognostic impact of 18F-FDG-PET/CT on the restaging process of cutaneous melanoma (CM) after surgery in patients with suspected distant recurrent disease or suspected metastatic progression disease. Materials and Methods: 74 patients surgically treated for CM underwent 18F-FDG-PET/CT for suspected distant recurrent disease or suspected metastatic progression disease.…

PharmacologyPET-CTmedicine.medical_specialtybusiness.industryProportional hazards modelMelanomaArea under the curveHistologyDiseasemedicine.disease030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisCutaneous melanomaMedical imagingmedicineRadiology Nuclear Medicine and imagingRadiologybusinessCurrent Radiopharmaceuticals
researchProduct

Focal Pancreatic Lesions: Role of Contrast-Enhanced Ultrasonography.

2021

The introduction of contrast-enhanced ultrasonography (CEUS) has led to a significant improvement in the diagnostic accuracy of ultrasound in the characterization of a pancreatic mass. CEUS, by using a blood pool contrast agent, can provide dynamic information concerning macro- and micro-circulation of focal lesions and of normal parenchyma, without the use of ionizing radiation. On the basis of personal experience and literature data, the purpose of this article is to describe and discuss CEUS imaging findings of the main solid and cystic pancreatic lesions with varying prevalence.

Medicine (General)medicine.medical_specialtydiagnostic imagingmedia_common.quotation_subjectClinical BiochemistryReview030218 nuclear medicine & medical imaging03 medical and health sciencesR5-9200302 clinical medicineParenchymaMedical imagingmedicinePancreatic massContrast (vision)pancreasmedia_commonbusiness.industryUltrasoundmedicine.diseasemedicine.anatomical_structure030220 oncology & carcinogenesisRadiologyUltrasonographyPancreasbusinessSettore MED/36 - Diagnostica Per Immagini E Radioterapiacontrast-enhanced ultrasoundContrast-enhanced ultrasoundDiagnostics (Basel, Switzerland)
researchProduct

Artificial Intelligence Applications on Restaging [18F]FDG PET/CT in Metastatic Colorectal Cancer: A Preliminary Report of Morpho-Functional Radiomic…

2022

Featured Application Based on results defined in this study, new investigations might propose morpho-functional-based radiomics algorithms for risk stratification with possible impact on treatment management in colorectal cancer. The aim of this study was to investigate the application of [F-18]FDG PET/CT images-based textural features analysis to propose radiomics models able to early predict disease progression (PD) and survival outcome in metastatic colorectal cancer (MCC) patients after first adjuvant therapy. For this purpose, 52 MCC patients who underwent [F-18]FDGPET/CT during the disease restaging process after the first adjuvant therapy were analyzed. Follow-up data were recorded f…

Fluid Flow and Transfer ProcessescolonradiomicsProcess Chemistry and TechnologyGeneral Engineeringpositron emission tomography-computed tomographycancercolon; cancer; radiomics; artificial intelligence; positron emission tomography-computed tomography; nuclear medicineGeneral Materials Sciencenuclear medicineartificial intelligenceInstrumentationComputer Science Applications
researchProduct